Successful treatment of myxedema coma with a combination of levothyroxine and liothyronine
Open Access
- 1 January 2019
- journal article
- research article
- Published by Japan Endocrine Society in Endocrine Journal
- Vol. 66 (5), 469-474
- https://doi.org/10.1507/endocrj.ej18-0469
Abstract
Myxedema coma is a rare endocrine emergency resulting from the decompensation of severe hypothyroidism, which is associated with a high mortality rate. It is characterized by the deterioration of mental status, hypothermia, hypotension, hyponatremia, and hypoventilation. Early disease diagnosis and advancements in intensive supportive care have reduced the mortality rate. Besides intensive supportive care, appropriate management of the underlying thyroid hormone deficiency is essential. However, as the disease is rare and unrecognized, evidence-based treatment of myxedema has not yet been established in many countries. An 84-year-old Japanese man with a history of Hashimoto’s thyroiditis was referred to our hospital. On arrival, conscious disturbance, hypothermia, hypotension, and hypoventilation were observed. He had discontinued thyroid hormone replacement therapy for a year. He was diagnosed with myxedema coma. Immediately, he received intensive supportive care and a combination therapy of 200 μg levothyroxine and 50 μg liothyronine until the fifth hospital day. Subsequently, monotherapy with levothyroxine was continued at a dose of 150 μg daily. The thyroid hormone level reached the normal range a few days later, and cardiovascular disease did not develop during hospitalization. This case demonstrated the efficacy of the combination of levothyroxine and liothyronine in treating myxedema coma.Keywords
This publication has 22 references indexed in Scilit:
- Thyroid EmergenciesMedical Clinics of North America, 2012
- Myxedema Coma: A New Look into an Old CrisisJournal of Thyroid Research, 2011
- Predictors of outcome in myxoedema comaCritical Care, 2008
- Predictors of outcome in myxoedema coma: a study from a tertiary care centreCritical Care, 2008
- Myxedema ComaEndocrinology and Metabolism Clinics of North America, 2006
- Thyroid Hormone and the Cardiovascular SystemThe New England Journal of Medicine, 2001
- Factors Associated with Mortality of Myxedema Coma: Report of Eight Cases and Literature SurveyThyroid®, 1999
- Myxoedema coma: Response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatmentIntensive Care Medicine, 1991
- T3 may be a better agent than T4 in the critically ill hypothyroid patientCritical Care Medicine, 1983
- INHIBITION OF CONVERSION OF THYROXINE TO TRIIODOTHYRONINE IN PATIENTS WITH SEVERE CHRONIC ILLNESSClinical Endocrinology, 1976